ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
x/twitter facebook linkedin bluesky youtube instagram iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Radiation Oncology

ELCC Session Offers Surgical Perspective in Context of Neoadjuvant Immunotherapy

Erin Jungmeyer
on: May 24, 2023In: Meeting News, Radiation Oncology, Surgical Oncology
ELCC Session Offers Surgical Perspective in Context of Neoadjuvant Immunotherapy

Presenter Dr. Alex Brunelli says neoadjuvant chemoimmunotherapy is a promising and well-tolerated treatment option in select patients with stage III NSCLC. Read more


Quality of Life After VATS and SABR for Early-stage Lung Cancer: The Lilac Study

Cecilia Pompili, MD PhD
+more
on: April 26, 2022In: Radiation Oncology, Surgical Oncology
Quality of Life After VATS and SABR for Early-stage Lung Cancer: The Lilac Study

SABR patients were stable during the 12 months while surgical patients reported clinically significant deterioration at 6 weeks. Read more

Management of Recurrences after Stereotactic Ablative Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer

Joe Y. Chang, MD, PhD
+more
on: March 09, 2022In: Radiation Oncology, Surgical Oncology
Management of Recurrences after Stereotactic Ablative Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer

Practical aspects of clinically managing operable SABR patients are important for the long-term care of this unique population. Read more

WHO, IAEA Publish Updated Guidance on Procurement of Radiotherapy Equipment

Matthew Beckett, MD, MSc
+more
on: February 23, 2022In: Radiation Oncology
WHO, IAEA Publish Updated Guidance on Procurement of Radiotherapy Equipment

To increase access to radiotherapy worldwide, new guidance from the WHO and IAEA includes a prioritized list of medical devices for cancer management. Read more

PREMER Results: A Q&A With Dr. Núria Rodriguez de Dios

Joy Curzio
on: February 23, 2022In: Radiation Oncology
PREMER Results: A Q&A With Dr. Núria Rodriguez de Dios

Dr. Rodriguez de Dios talks with ILCN about the implications of the PREMER study, a phase III trial comparing PCI with and without hippocampal avoidance in SCLC. Read more

Spine Stereotactic Radiosurgery: A Critical Evaluation of the Evidence to Guide Clinical Practice

Rupesh Kotecha
on: October 15, 2021In: Radiation Oncology
Spine Stereotactic Radiosurgery: A Critical Evaluation of the Evidence to Guide Clinical Practice

Spine metastases represent a common complication of lung cancer and other cancers, with approximately 40% of patients developing clinically significant spinal metastatic disease and up to 90% developing subclinical micrometastases. […] Read more

Radiotherapy Inaccessibility in Lung Cancer Care: An Ongoing Crisis

Federico Maldonado Magos
+more
on: August 27, 2021In: Radiation Oncology
Radiotherapy Inaccessibility in Lung Cancer Care: An Ongoing Crisis

A leading cause of mortality worldwide, cancer was tied to nearly 10 million deaths in 2020.1 Lung cancer has remained unchallenged for more than 30 years as the most commonly […] Read more

Cardiac Toxicity of Lung Cancer Radiotherapy

Kathryn Banfill
+more
on: July 16, 2021In: Radiation Oncology
Cardiac Toxicity of Lung Cancer Radiotherapy

A 65-year-old patient with stage III NSCLC comes to your clinic to discuss concurrent chemoradiotherapy. She has a history of ischemic heart disease, and 4 years ago an angiogram demonstrated […] Read more

Hippocampal-Sparing Brain Irradiation: The Future of Brain Metastases Treatment and Prevention?

Lizza Hendriks
+more
on: July 16, 2021In: Radiation Oncology
Hippocampal-Sparing Brain Irradiation: The Future of Brain Metastases Treatment and Prevention?

Brain metastases (BMs) are frequently diagnosed in patients with SCLC and NSCLC, although the incidence is highest in SCLC.1 ,2 ,3  BMs are a negative prognostic factor and are associated […] Read more

Prophylactic Radiotherapy: A Case for Patients at High Risk of Brain Metastases

Oscar Arrieta
+more
on: June 18, 2021In: Radiation Oncology
Prophylactic Radiotherapy: A Case for Patients at High Risk of Brain Metastases

Prophylactic radiotherapy for the prevention of brain metastases (Table 1) has not been considered a standard practice outside of limited stage SCLC, particularly amid the surge and approval of novel […] Read more

12345

SEARCH ILCN

Archives

POPULAR ARTICLES

Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2024 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy